Clinical Trials

Showing trials with last updates posted in 2025.

NCT07270263 | RECRUITING | NA
100 participants

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-26
Start Date:
2024-11-22
Completion:
2026-04-30
Conditions
  • Lymphoma
  • Leukemia
  • Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
  • Venous Thromboembolic Disease
  • VTE (Venous Thromboembolism)
  • PE - Pulmonary Embolism
  • Hematologic Malignacies
Interventions
  • DRUG
No Results Yet
NCT07007117 | RECRUITING | PHASE1
38 participants

PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-26
Start Date:
2025-06-20
Completion:
2032-06-30
Conditions
  • Refractory Neuroblastoma
  • Relapsed Neuroblastoma
  • High-Risk Neuroblastoma
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page